Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has provided an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. held its 2024 Annual General Meeting, where all proposed resolutions were approved, including the appointment of a new executive director and auditors. The company also established a Commercialisation Committee, indicating a strategic focus on expanding its market reach and operational capabilities.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the medical technology industry. It focuses on developing and commercializing innovative medical devices and solutions, with a strong emphasis on robotic-assisted surgical systems.
Average Trading Volume: 8,265,484
Technical Sentiment Signal: Buy
Current Market Cap: HK$16.3B
See more data about 2252 stock on TipRanks’ Stock Analysis page.